Literature DB >> 9353290

The oxidative half-reaction of xanthine dehydrogenase with NAD; reaction kinetics and steady-state mechanism.

C M Harris1, V Massey.   

Abstract

The reaction between reduced xanthine dehydrogenase (XDH) from bovine milk and NAD has been studied in detail. An understanding of this reaction is necessary for a complete description of XDH turnover with its presumed natural electron acceptor and to address the preference of XDH for NAD over oxygen as a substrate. The reaction between pre-reduced XDH and NAD was studied by stopped-flow spectrophotometry. The reaction was found to involve two rounds of oxidation with 2 eq of NAD. The first round goes to completion, and the second round reaches a slightly disfavored equilibrium. Rapid binding of NAD with an apparent Kd of 25 +/- 2 microM is followed by NAD reduction at a rate constant of 130 +/- 13 s-1. NADH dissociation at a rate constant of 42 +/- 12 s-1 completes a round of oxidation. These steps have been successfully tested and modeled to repeat themselves in the second round of oxidation. The association rate constant for NAD binding was estimated to be much greater than any rate constant measured in the oxidation by molecular oxygen, thus explaining how NAD competes with oxygen for reducing equivalents. Rate constants for NAD reduction and NADH dissociation are respectively 21- and 7-fold greater than kcat, indicating that the reductive half-reaction of the enzyme by xanthine is mostly rate-limiting in xanthine/NAD turnover. A steady-state mechanism for XDH is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353290     DOI: 10.1074/jbc.272.45.28335

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

Review 2.  Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases.

Authors:  Luisa B Maia; José J G Moura
Journal:  J Biol Inorg Chem       Date:  2015-01-15       Impact factor: 3.358

Review 3.  Nitrite signaling in pulmonary hypertension: mechanisms of bioactivation, signaling, and therapeutics.

Authors:  Marta Bueno; Jun Wang; Ana L Mora; Mark T Gladwin
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

Review 4.  Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how.

Authors:  Nadiezhda Cantu-Medellin; Eric E Kelley
Journal:  Nitric Oxide       Date:  2013-02-27       Impact factor: 4.427

Review 5.  Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology.

Authors:  Enrico Garattini; Ralf Mendel; Maria João Romão; Richard Wright; Mineko Terao
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

6.  Hydrogen peroxide is the major oxidant product of xanthine oxidase.

Authors:  Eric E Kelley; Nicholas K H Khoo; Nicholas J Hundley; Umair Z Malik; Bruce A Freeman; Margaret M Tarpey
Journal:  Free Radic Biol Med       Date:  2009-11-24       Impact factor: 7.376

Review 7.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

8.  Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPARα.

Authors:  Takumi Kanemitsu; Yuya Tsurudome; Naoki Kusunose; Masayuki Oda; Naoya Matsunaga; Satoru Koyanagi; Shigehiro Ohdo
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

Review 9.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

Review 10.  A new paradigm for XOR-catalyzed reactive species generation in the endothelium.

Authors:  Eric E Kelley
Journal:  Pharmacol Rep       Date:  2015-05-23       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.